Laboratory MSO Kickbacks: Investment Returns Tied to Test Referrals

Laboratory MSO kickbacks are payments for test referrals routed through a management services organization and presented as investment distributions. The physician orders the tests, the testing generates revenue, and some of the money comes back to the physician. If you see both the referral reports and the distribution ledger, you may know what the investment paperwork leaves out: what the doctor had to send to get paid.

Do Doctors Get Kickbacks for Ordering Tests?

Yes. The Justice Department’s laboratory cases describe payments to doctors for ordering tests, including payments disguised as MSO distributions, consulting fees and medical-director fees. The alleged arrangements connect the physician’s financial return to the patients sent for testing.

Patients can receive tests they do not need, and taxpayers fund the bill through programs such as Medicare and Medicaid. The patient relies on a medical recommendation while the alleged arrangement gives the referring physician a financial reason to choose the testing business.

An MSO arrangement gives that payment a business name and an intermediary. To understand what the payment bought, we examine the investment, the services promised, the work performed and the referrals behind the return.

How Laboratory Profit Reaches a Referring Physician

The government alleged that Little River Healthcare and other hospitals paid part of their laboratory profits to recruiters, who passed money to referring physicians. The MSO sat between the testing business and the doctor receiving the payment.

The Justice Department’s April 2022 account of its complaint describes that path through True Health Diagnostics, Boston Heart Diagnostics and Little River Healthcare. It also explains the sales incentive. Employees of True Health and Boston Heart allegedly used the payments to doctors to increase referrals, which increased their own bonuses and commissions.

That puts a sales payment and a physician distribution on opposite sides of the same referral. The laboratory’s sales employee wants the orders. The physician chooses the testing destination. The recruiter connects them, and part of the testing revenue returns through the management organization.

An insider may see only one account in that chain. A hospital’s payment to a recruiter and an MSO’s payment to a physician become much more informative when connected to the same testing business. The management invoice describes an expense. The referral report can show the business that expense brought in.

Little River, True Health and Boston Heart

The alleged Little River and True Health laboratory kickback scheme linked a referring physician, a hospital and the laboratory performing the testing. Little River Healthcare was a critical access hospital in Rockdale, Texas. True Health operated a clinical laboratory in Frisco, Texas, while Boston Heart operated in Framingham, Massachusetts.

The government’s allegations trace different routes through that network. In the September 2025 settlements, one physician allegedly received payments from Ascend MSO of TX and Herculis MG for ordering tests from Little River and Boston Heart. Another allegedly received payments from Ascend and Eridanus MG for referrals involving Little River, True Health and Boston Heart.

Consulting for a Board the Government Says Did Not Exist

The government’s April 2022 complaint account alleged that True Health paid monthly consulting fees to a top-referring doctor for participating in an advisory board that did not exist. It also alleged processing and handling payments to draw-site companies and waivers of patient copayments and deductibles.

A contract could describe participation on an advisory board. According to the complaint, the board itself was missing. For someone inside the laboratory, knowing whether the promised work happened can explain more than the title on the payment.

The Criminal Trial Traced Money Through Shell Companies

In its November 2023 account of the criminal trial, the Justice Department described a participant using sham trusts and shell corporations to launder health care kickback proceeds. The jury found five defendants, including laboratory and hospital executives, guilty of a kickback conspiracy.

That criminal account adds another part of the payment trail: entities created to move the proceeds. The person who knows what a company actually did may also know why its name appears between the testing revenue and the recipient.

Civil Settlements With Former Executives

Little River’s former chief executive agreed to a $5,343,630 civil settlement announced in October 2024 and accepted responsibility for the allegations against him. The government’s account described a physician telling the hospital about his potential referral volume before the executive agreed to monthly payments disguised as medical-director fees. The sales prospect came before the job.

True Health’s former chief executive agreed in September 2025 to pay $4.25 million to settle allegations that he caused false claims to Medicare, Medicaid and TRICARE. The alleged conduct included physician payments disguised as MSO distributions. The department alleged that he continued the arrangement after a warning that the marketers “are a powder keg waiting to explode on us.” Physicians and marketers also entered separate civil settlements.

In June 2026, Boston Heart’s former chief executive and former sales executive agreed to pay $1.2 million together. The government alleged that marketers, including Boston Heart employees, paid doctors through MSO distributions for referrals to Texas hospitals. According to the allegations, Boston Heart performed the testing, including tests patients did not need. The executives allegedly expanded the hospital arrangement after recommendations to stop.

In that announcement, the department put its civil MSO settlements since 2019 at over $61 million, including settlements with more than 50 physicians.

When the Investment Return Follows the Orders

If you see lab MSO distributions based on number of tests ordered, the payment calculation connects the doctor’s return directly to testing volume. We examine how the distribution was calculated alongside the ownership agreement, the services performed and the referrals credited to that physician.

RDx Bioscience supplies a parallel. In its January 2024 settlement announcement, the Justice Department alleged that payments through a management services organization were disguised as investment returns but offered to induce orders for RDx tests.

The same announcement described another route. Marketers BeauMed Consultants and Ralston Health Group allegedly paid health care providers through consulting or medical-director fees to induce laboratory orders. A professional title and an ownership return supplied different descriptions for the alleged referral payment.

For an insider, the useful comparison is concrete. The investment paperwork records the capital and ownership interest. The service agreement describes the work purchased. We compare the fee with the work and its fair market value, including whether the recipient actually provided the service. The distribution calculation shows what determined the payment. If a referral report also supplies the numbers used to pay the physician, we examine that connection with you.

In a separate urine-testing matter, Cordant Health Solutions settled referral-payment allegations in 2020. The alleged payments went to Northwest Physicians Laboratories and Genesis Marketing Group for urine-test referrals.

The Intermediary Can Explain the Payment

A whistleblower’s complaint against Boston Heart described a separate packaging-fee arrangement in which third parties passed payments to physician offices. It quoted a laboratory representative explaining the reason for the extra company:

In that account, the answer to a prohibition on direct payments was another company in the middle.

The complaint also alleged that a representative arranged packaging payments to a physician’s spouse with a different surname. It alleged that intermediaries kept part of each packaging fee and paid the rest to someone in the physician’s office, even when that person had not drawn the blood. The recipient’s identity becomes part of the commercial explanation: who received the money, how they were connected to the ordering practice, and what work the payment supposedly covered.

Boston Heart agreed to a civil settlement of $26,670,000 in 2019 over alleged illegal inducements to referring physicians.

Referral Payments Can Arrive as Free Work

A laboratory can give a referring practice something valuable by doing work the practice would otherwise have to pay for.

How to Detect and Deter Laboratory Fraud?

The useful comparison connects the payment arrangement to the actual testing: the management agreement, distribution records, referral reports, orders, results and claims.

The clinical paperwork and the money sit in different places. Under Medicare’s laboratory documentation rule, the treating practitioner orders the test and keeps the patient’s medical-necessity documentation. The entity submitting the claim keeps what it received from the ordering practitioner and documentation that the claim accurately reflects that information. An insider who understands that separation can explain why the laboratory’s billing file tells only part of the story.

Our review follows those connections. The agreement describes what the recipient was supposed to do. The payment records identify who received the money. Referral reports connect the ordering practice to the testing business. Requisitions, results and claims let us examine what was requested, what was performed and what the payer was charged.

The unit being counted matters, too. A requisition and a test are different things. The Boston Heart whistleblower complaint alleged that its Complete One panel allowed a physician to order 25 tests with a single checkbox. A compensation report counting orders and a billing report counting tests can therefore describe different quantities from the same ordering activity.

What a Laboratory Insider Can See

Sales, billing and practice staff see different parts of the same relationship. A sales employee may know how an investment offer entered the referral conversation and how commissions followed the business. A person handling distributions may know which referral report supplied the payment calculation.

Billing staff can connect the ordering information to the claims submitted. A practice administrator may know whether laboratory-paid staff performed office duties, or whether a consulting payment corresponded to actual work. A physician may know what was promised for sending testing to the hospital or laboratory.

The government alleged a nonexistent advisory board at True Health, expansion after warnings at Boston Heart, and medical-director payments after a referral-volume discussion at Little River. Each allegation depends on knowledge of what happened inside the business, beyond the name on the contract.

What Are the Whistleblower Laws in Healthcare?

The False Claims Act is the whistleblower law behind these laboratory referral-payment cases. A whistleblower filed the True Health qui tam case, and the United States joined against the former chief executive. The department announced that the whistleblower would receive a share of the executive’s settlement.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. For someone who knows how the distribution, the referral and the claim fit together, the commercial arrangement is the starting point for a conversation with us.

How to Report Laboratory Fraud?

If you know why a physician’s distribution followed laboratory referrals, speak with our whistleblower experts about the arrangement you saw. We build your strongest laboratory kickback case with you, connecting the payments, orders and decisions inside the business. We bring in healthcare whistleblower lawyers who understand MSO referral arrangements and stay beside you throughout the case.